Gene · 5789
Papers1,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers. | BMC Pulm Med | 2022 | 36123678 | PubTator, text mining | PubMed |
| Eight gene mutation-based polygenic hazard score as a potential predictor for immune checkpoint inhibitor therapy outcome in metastatic melanoma. | Front Mol Biosci | 2022 | 36120536 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the prognosis and immunological role of AKAP12: A potential biomarker for resistance to anti-VEGF inhibitors. | Front Genet | 2022 | 36110213 | PubTator, text mining | PubMed |
| Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk Neuroblastoma. | Cancer Discov | 2022 | 36108156 | PubTator, text mining | PubMed |
| The progress of research into pseudophosphatases. | Front Public Health | 2022 | 36106167 | PubTator, text mining | PubMed |
| Pancancer analysis of a potential gene mutation model in the prediction of immunotherapy outcomes. | Front Genet | 2022 | 36092890 | PubTator, text mining | PubMed |
| Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach. | Biochem Biophys Rep | 2022 | 36090591 | PubTator, text mining | PubMed |
| SLITRK1-mediated noradrenergic projection suppression in the neonatal prefrontal cortex. | Commun Biol | 2022 | 36085162 | PubTator, text mining | PubMed |
| Uncovering Oncogenic Mechanisms of Tumor Suppressor Genes in Breast Cancer Multi-Omics Data. | Int J Mol Sci | 2022 | 36077026 | PubTator, text mining | PubMed |
| Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers. | Cancer Res | 2022 | 36074020 | PubTator, text mining | PubMed |
| Lung- and liver-dominant phenotypes of Korean eight constitution medicine have different profiles of genotype associated with each organ function. | Physiol Rep | 2022 | 36065883 | PubTator, text mining | PubMed |
| Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma. | Front Immunol | 2022 | 36059494 | PubTator, text mining | PubMed |
| Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers. | Genome Med | 2022 | 36045381 | PubTator, text mining | PubMed |
| Bioinformatics and System Biological Approaches for the Identification of Genetic Risk Factors in the Progression of Cardiovascular Disease. | Cardiovasc Ther | 2022 | 36035865 | PubTator, text mining | PubMed |
| Advances in molecular characterization of myeloid proliferations associated with Down syndrome. | Front Genet | 2022 | 36035173 | PubTator, text mining | PubMed |
| A review on the role of miRNA-324 in various diseases. | Front Genet | 2022 | 36035118 | PubTator, text mining | PubMed |
| Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case report. | Front Pharmacol | 2022 | 36034832 | PubTator, text mining | PubMed |
| Identification of an Epigenetic Signature for Coronary Heart Disease in Postmenopausal Women's PBMC DNA. | Mediators Inflamm | 2022 | 36032780 | PubTator, text mining | PubMed |
| Roles of microRNAs in Hepatitis C Virus Replication and Pathogenesis. | Viruses | 2022 | 36016398 | PubTator, text mining | PubMed |
| The Function of N-Myc Downstream-Regulated Gene 2 (NDRG2) as a Negative Regulator in Tumor Cell Metastasis. | Int J Mol Sci | 2022 | 36012631 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5789/papers?page=18